We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
-2.42%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$5.17B
AUM Growth
-$545M
Cap. Flow
-$309M
Cap. Flow %
-5.98%
Top 10 Hldgs %
66.94%
Holding
136
New
4
Increased
19
Reduced
43
Closed
14

Top Buys

Rank Stock Value
1
DG icon
Dollar General
DG
+$260M
2
FRC
First Republic Bank
FRC
+$125M
3
BABA icon
Alibaba
BABA
+$9.42M
4
BIDU icon
Baidu
BIDU
+$4.48M
5
INCY icon
Incyte
INCY
+$3.06M

Sector Composition

Rank Sector Weight
1 Financials 26.08%
2 Healthcare 25.94%
3 Consumer Discretionary 13.86%
4 Communication Services 13.8%
5 Consumer Staples 10.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MD icon
101
Pediatrix Medical
MD
$2.18B
$950K 0.02%
14,700
-2,300
-14% -$153K
TGT icon
102
Target
TGT
$66.4B
$921K 0.02%
11,200
AZO icon
103
AutoZone
AZO
$51.2B
$866K 0.02%
1,087
DHR icon
104
Danaher
DHR
$141B
$831K 0.02%
13,048
DFS
105
DELISTED
Discover Financial Services
DFS
$821K 0.02%
16,110
OXFD
106
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$698K 0.01%
70,460
TMO icon
107
Thermo Fisher Scientific
TMO
$215B
$656K 0.01%
4,640
WP
108
DELISTED
Worldpay, Inc.
WP
$614K 0.01%
+11,400
New +$558K
RDUS
109
DELISTED
Radius Health, Inc.
RDUS
$608K 0.01%
19,330
+1,000
+5% +$34.6K
ACAD icon
110
Acadia Pharmaceuticals
ACAD
$4.46B
$570K 0.01%
20,390
LLY icon
111
Eli Lilly
LLY
$1.09T
$511K 0.01%
7,100
ENDP
112
DELISTED
Endo International plc
ENDP
$493K 0.01%
17,500
ICPT
113
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$488K 0.01%
3,800
XLRN
114
DELISTED
Acceleron Pharma
XLRN
$433K 0.01%
16,400
PTCT icon
115
PTC Therapeutics
PTCT
$6.18B
$410K 0.01%
63,700
ESPR
116
DELISTED
Esperion Therapeutics
ESPR
$321K 0.01%
19,000
ACOR
117
DELISTED
Acorda Therapeutics
ACOR
$264K 0.01%
83
LUMO
118
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$241K ﹤0.01%
1,471
ASX icon
119
ASE Group
ASX
$70.7B
$222K ﹤0.01%
37,800
INFI
120
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$214K ﹤0.01%
40,680
BLUE
121
DELISTED
bluebird bio
BLUE
$212K ﹤0.01%
386
BAP icon
122
Credicorp
BAP
$30.6B
$118K ﹤0.01%
900
AIG icon
123
American International
AIG
$42.8B
-4,219,465
Closed -$261M
BFH icon
124
Bread Financial
BFH
$4.37B
-669,465
Closed -$148M
DUK icon
125
Duke Energy
DUK
$101B
-22,000
Closed -$1.57M

Similar funds

C WorldWide Group's Q1 2016 Portfolio in Review

As of Q1 2016, C WorldWide Group held 136 positions worth $5.17B, down 9.5% from $5.72B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

C WorldWide Group withdrew a net $309M in Q1 2016, closing 14 positions and reducing 43 holdings. Its most notable exit was American International, an estimated $261M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, C WorldWide Group opened a new position in Incyte worth $2.97M.

  • C WorldWide Group's largest Q1 2016 buy was Incyte: 41,000 shares worth $2.97M.
  • C WorldWide Group added most to Dollar General in Q1 2016, an estimated $260M increase.
  • C WorldWide Group's biggest Q1 2016 reduction was Home Depot, cutting an estimated $54.4M.
  • C WorldWide Group fully exited American International in Q1 2016, selling an estimated $261M.
  • C WorldWide Group's ten largest holdings make up 67% of its $5.17B portfolio in Q1 2016.
  • C WorldWide Group opened 4 new positions and closed 14 in Q1 2016.
  • C WorldWide Group's portfolio value fell 9.5% quarter-over-quarter to $5.17B.

Based on C WorldWide Group's 13F filing for Q1 2016, filed 4 May 2016.